TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,440 | -42.7% | 16,964 | -41.8% | 0.06% | -39.6% |
| Q2 2023 | $457,912 | -6.4% | 29,148 | -1.8% | 0.10% | -4.0% |
| Q1 2023 | $489,386 | +74729.7% | 29,696 | -29.2% | 0.10% | -28.6% |
| Q4 2022 | $654 | -99.7% | 41,915 | +113.2% | 0.14% | +122.2% |
| Q3 2022 | $255,000 | -47.1% | 19,656 | -42.7% | 0.06% | -45.2% |
| Q2 2022 | $482,000 | +15.6% | 34,321 | +17.8% | 0.12% | +9.5% |
| Q1 2022 | $417,000 | +64.2% | 29,142 | +56.3% | 0.10% | +64.1% |
| Q4 2021 | $254,000 | -3.4% | 18,646 | +16.2% | 0.06% | -13.5% |
| Q3 2021 | $263,000 | +13.9% | 16,041 | +17.1% | 0.07% | +15.6% |
| Q2 2021 | $231,000 | +1.8% | 13,704 | +10.4% | 0.06% | -3.0% |
| Q1 2021 | $227,000 | – | 12,410 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |